VIAVI T/Rx Selected by U.S. Army Threat Systems Management Office for Critical Range Modernization Initiative

VIAVI wins U.S. Army contract for T/Rx EMS systems at five new test ranges.

What the company is saying

VIAVI Solutions Inc. announces that its T/Rx software defined transceiver system has been selected by the U.S. Army's Threat Systems Management Office (TSMO) to provide electromagnetic spectrum environments at Army test ranges now open to private industry. The announcement frames this as supporting the Test Range Private Industry Initiative, which opens five premier facilities to commercial developers of drones, counter-drone systems, long-range fires, and low-cost interceptors. The company emphasizes the technical capabilities of the T/Rx system, including EMS monitoring, recording, analysis, and transmission, and highlights its ability to replicate contested electromagnetic environments. Doug Russell, Senior Vice President and General Manager, Aerospace & Defense at VIAVI, is quoted stressing the importance of the Army's acquisition reform and the realism the T/Rx brings to test events. The release specifically mentions a recurring electromagnetic unreliability test at Camp Grayling in September 2026, where the T/Rx system demonstrated its ability to reproduce electronic warfare conditions observed in Ukraine. The tone is confident and positions VIAVI as an enabler of rapid innovation for next-generation military technologies.

What the data suggests

The announcement confirms that VIAVI's T/Rx system has been operationally deployed at Camp Grayling, one of five Army test ranges opened to private industry under the Test Range Private Industry Initiative. The system was used in a recurring electromagnetic unreliability test in September 2026, demonstrating its ability to generate complex, realistic EMS environments, including scenarios modeled on electronic warfare conditions from Ukraine. The T/Rx is described as a compact, rugged, commercial software defined transceiver capable of simultaneous signal generation and collection, supporting diverse and frequency-agile test scenarios. The only quantitative figures disclosed are the number of test ranges (five) and the timing of the Camp Grayling test (September 2026). No financial terms, contract value, or revenue impact are provided, so the materiality of the contract to VIAVI's financials cannot be assessed. The operational facts are specific, but the scale and profitability of the Army engagement remain undefined.

Analysis

The announcement is positive in tone, highlighting VIAVI's selection by the U.S. Army's TSMO and the operational deployment of the T/Rx system at Camp Grayling in September 2026. Several claims are realised and supported by operational facts, such as the number of test ranges (five) and the recent demonstration of the system's capabilities. However, the narrative includes some inflated language, such as 'industry-leading' and broad statements about accelerating warfighter capability, without quantitative evidence or financial disclosure. The forward-looking content is limited, mainly to aspirations of supporting future technology development. No financial terms, contract value, or profitability metrics are disclosed, capping the signal at weak_positive per the Disclosure Completeness Rule. The gap between narrative and evidence is moderate: technical and operational facts are clear, but the investment materiality remains unquantified.

Risk flags

• ●The absence of disclosed contract value or financial terms means investors cannot assess the revenue or margin impact of the Army engagement, limiting visibility into the deal's materiality for VIAVI.
• ●The announcement relies on qualitative claims such as 'industry-leading' and 'accelerates capability delivery' without comparative or quantitative evidence, introducing the risk that the technical or commercial significance may be overstated.
• ●Future revenue from this initiative depends on continued Army use and possible expansion to other test ranges or customers, but no commitments or follow-on contracts are described, so the sustainability of this business is uncertain.

Bottom line

VIAVI's selection by the U.S. Army's TSMO to supply T/Rx EMS systems for five newly opened test ranges is a clear operational win and demonstrates the system's technical relevance, particularly with a successful demonstration at Camp Grayling in September 2026. The announcement underscores the strategic importance of the Test Range Private Industry Initiative and highlights VIAVI's ability to simulate complex electronic warfare environments, including those observed in Ukraine. However, the lack of any disclosed contract value, revenue guidance, or financial impact means investors cannot judge the scale or profitability of this win. The credibility of the technical claims is supported by operational deployment, but the commercial significance remains unquantified. Investors should watch for future updates on contract size, additional deployments, or customer wins to assess the true financial impact. The key takeaway is that VIAVI has secured a high-profile defense customer, but the investment case depends on future financial disclosures.

Announcement summary

(NASDAQ:VIAV) VIAVI Solutions Inc. announced that the U.S. Army's Threat Systems Management Office (TSMO), under Portfolio Acquisition Executive C2/CC2, has selected the VIAVI T/Rx software defined transceiver system to provide electromagnetic spectrum (EMS) environments at Army test ranges recently opened to private industry. The selection is part of the Test Range Private Industry Initiative, which opens five premier range facilities to commercial developers of drones, counter-drone systems, long-range fires, and low-cost interceptors to support rapid innovation at scale. The initiative allows companies, including those without existing government contracts, to access range infrastructure and accelerate the development of emerging warfighter technologies. Realistic testing at these ranges requires the ability to replicate contested electromagnetic environments encountered on the modern battlefield. TSMO will use the VIAVI T/Rx system to fulfill a large portion of this requirement, leveraging its EMS monitoring, recording, analysis, and transmission capabilities. Doug Russell, Senior Vice President and General Manager, Aerospace & Defense, VIAVI Solutions, stated that the Army's test range expansion initiative accelerates capability delivery to warfighters and that VIAVI is proud to be selected by TSMO. He added that the T/Rx was designed to deliver the complexity and programmability that modern test events demand and that VIAVI looks forward to supporting the development of the next generation of drones, counter-drones, and interceptors. Camp Grayling, one of the designated sites under the Test Range Private Industry Initiative, hosted a recurring electromagnetic unreliability test in September 2026. The VIAVI T/Rx system delivered on-demand EMS complexity at Camp Grayling, which is designed to reproduce contested electronic warfare conditions observed in Ukraine and enable developers to harden drone and counter-drone systems accordingly. The T/Rx system is a compact, rugged, commercial software defined transceiver that combines simultaneous signal generation and collection in a single field-deployable unit. The T/Rx operates across a broad range of instantaneous bandwidth, enabling test range operators to create complex, diverse electromagnetic environments on demand. The system generates representative waveforms, frequency-agile emitters, and multi-signal scenarios that replicate real-world contested EMS conditions.

Disagree with this article?